Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Cash & Equivalents (2016 - 2026)

Innoviva filings provide 17 years of Cash & Equivalents readings, the most recent being $550.9 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 80.66% to $550.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $550.9 million, a 80.66% increase, with the full-year FY2025 number at $550.9 million, up 80.66% from a year prior.
  • Cash & Equivalents hit $550.9 million in Q4 2025 for Innoviva, up from $476.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $550.9 million in Q4 2025 to a low of $43.3 million in Q2 2021.
  • Median Cash & Equivalents over the past 5 years was $238.8 million (2024), compared with a mean of $257.5 million.
  • Biggest five-year swings in Cash & Equivalents: tumbled 89.53% in 2021 and later soared 555.45% in 2022.
  • Innoviva's Cash & Equivalents stood at $201.5 million in 2021, then surged by 44.42% to $291.0 million in 2022, then tumbled by 33.51% to $193.5 million in 2023, then surged by 57.59% to $305.0 million in 2024, then surged by 80.66% to $550.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $550.9 million (Q4 2025), $476.5 million (Q3 2025), and $397.5 million (Q2 2025) per Business Quant data.